LIQUIDITY ALERT: Radient Pharma’s Current Deficit Down 67.5%
May 2, 2010
Radient Pharmaceuticals Corporation’s working capital deficit narrowed 67.5%, or US$8,775,694, from US$12,996,526 at December 31, 2008, to US$4,220,832 at December 31, 2009.
The Company reported current assets of US$507,845 and current…
COMPANIES:
Radient Pharmaceuticals Corporation